| Autor: |
Buqué A; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States. Electronic address: abm2013@med.cornell.edu., Montrose DC; Department of Pathology, Stony Brook University, Stony Brook, NY, United States; Stony Brook Cancer Center, Stony Brook, NY, United States., Galluzzi L; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States; Sandra and Edward Meyer Cancer Center, New York, NY, United States; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States. Electronic address: deadoc80@gmail.com. |
| Abstrakt: |
Competing Interests: Conflict of interest L.G. holds or has been holding research contracts with Lytix Biopharma Onxeo and Promontory, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Sotio, Promontory, Noxopharm, EduCom and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. A.B. and D.C.M. have no conflicts to disclose. |
